Journal for ImmunoTherapy of Cancer

Published by: Biomed Central Ltd  

People

  1. Cheung
    Cheung
  2. Guo
    Guo
  3. Espinosa Cotton
    Espinosa Cotton
  4. Xu
    Xu
  5. Cheung
    Cheung
  6. Feng
    Feng
  7. Modak
    Modak
  8. Monette
    Monette
  9. Tran
    Tran

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  2. GSK Faculty (8)
  3. Neuroblastoma Service (8)
  4. Pediatrics, Department of (8)
  5. Tow Center for Developmental Oncology (TCDO) (8)
  6. Center for Molecular Imaging and Biotechnology (7)
  7. Sloan Kettering Institute Postdocs (7)
  8. Alumni (GSK) (1)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  10. General Oncology Service (1)
Search Within
  1. "Neuroblastoma Service"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  2. GSK Faculty (8)
  3. Neuroblastoma Service (8)
  4. Pediatrics, Department of (8)
  5. Tow Center for Developmental Oncology (TCDO) (8)
  6. Center for Molecular Imaging and Biotechnology (7)

More Groups

People
  1. Nai-Kong Cheung (8)
  2. Hong-Fen Guo (5)
  3. Jeong A Park (4)
  4. Madelyn Espinosa Cotton (4)
  5. Hong Xu (2)
  6. Sayed Shahabuddin Hoseini (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (3)
  5. 2020 (1)
Publishers
  1. Biomed Central Ltd (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
    Journal Article

    Park, J. A.; Espinosa-Cotton, M.; Guo, H. F.; Monette, S.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • A novel humanized T cell-engaging CD24XCD3 bispecific antibody for CD24-positive solid tumors
    Meeting Abstract

    Espinosa-Cotton, M.; Guo, H. F.; Cheung, N. K.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies
    Journal Article

    Park, J. A.; Cheung, N. V.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
    Journal Article

    Lin, T. Y.; Park, J. A.; Long, A.; Guo, H. F.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia
    Journal Article

    Hoseini, S. S.; Vadlamudi, M.; Espinosa-Cotton, M.; Tran, H.; Feng, Y.; Guo, H. F.; Xu, H.; Cheung, I.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
    Journal Article

    Park, J. A.; Santich, B. H.; Xu, H.; Lum, L. G.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies
    Journal Article

    Hoseini, S. S.; Espinosa-Cotton, M.; Guo, H. F.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save

    • Journal for ImmunoTherapy of Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Emp Oyer(s)) 2025
    Journal for ImmunoTherapy of Cancer 20511426 Unknown
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2025
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 The Author(s)
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 BMJ Group
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer 2051-1426 Bmc
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2024
    Journal for ImmunoTherapy of Cancer 2017 Nov 8-12 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Bmj
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s))
    Unknown (2051-1426) 2051-1426 Biomed Central Ltd